Genedrive PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genedrive PLC with three other
companies in this sector in the United Kingdom:
Tissue Regenix Group PLC
sales of £5.23 million [US$6.89 million]
of which 41%
(£5.03 million [US$6.62 million]
of which 100%
was Drug Discovery), and
(£7.25 million [US$9.55 million]
Genedrive PLC reported sales of £5.79 million (US$7.62 million)
June of 2017.
increase of 14.3%
versus 2016, when the company's sales were £5.06 million.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Genedrive PLC had sales
of £5.56 million.
Sales of Diagnostics Segment saw an increase
that was more than double the company's growth rate: sales were up
37.4% in 2017, from
£1.91 million to £2.62 million.
Not all segments of Genedrive PLC experienced an increase in sales in 2017:
sales of Pharmacogenomics Services fell 4.4% to £1.10 million.